4587.T
PeptiDream Inc.
プライム · 医薬品 · 医薬品 · JP
JPY 1,112.00
+0.04%Year over year
Reported trailing growth
- Revenue
- -59.2%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +68.0%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -11.6%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026